About DP-b99DP-b99 is a unique neuroprotective a series of brain a number of brain damaging processes in stroke patients and emerged from D-Pharm ‘s proprietary Membrane Activated Chelator platform technology. D-Pharm successfully completed extensive testing of DP-b99. Then preclinical and phase I and phase II clinical trials in the USA window.nd clinical studies indicate a favorable efficacy and safety profile for DP-b99. In the recently completed Phase IIb trial in 150 ischemic stroke patients, DP-b99 of two times the %age of patients who have increased completely recovered from ischemic stroke. DP-b99 within a within a 9 hours therapeutic window.
The second leading cause of death worldwide, stroke is the leading cause of serious long-term disability, 15 percent to 30 percent of stroke survivors experience permanent disability. According to the American Heart Association, the estimated direct and indirect costs of a stroke in 2009 in the U.S. 68,900,000,000th 68,900,000,000th Only about 2 to 5 percent of acute stroke patients eligible for treatment with tissue plasminogen activator , the only FDA approved drug for the treatment of acute stroke.
D-Pharm Receives FDA Clearance to a Phase III study of DP-b99 in acute stroke patients beginD-Pharm announced today that its Investigational New Drug application for a pivotal Phase III study of DP-b99 was in acute ischemic stroke patients the U.S.Asfora is currently case as a neurosurgeon by Sanford Clinic in Sioux. He has specialized in adult and pediatric Neurosurgical, spinal column surgery, brain tumor surgery, cerebro surgery, peripheral nerve surgery, radiosurgery and functional neurosurgery including the Deep Brain Stimulation Movement Disorders. Asfora be Member of the Board the American Board of Neurological Surgery and the Royal College of Physicians and Surgeons of United States certified in. Asfora to Sanford Health since 2007 and has become working as neurosurgeon since 1989. Asfora wrote dozens of publications in issues related to neurosurgery. He also has number medical equipment in hospitals over the world, comprehensive, integrated including:..
J. Ganesh, UNICEF director of the HIV / AIDS programs in India, said the idea of the Programme is assistance of youths such how boy people prefer to to hear other teenagers and HIV / AIDS issues. Ganesha said if this project is effective, it will be removed nationwide. According to to Times, the UNICEF and Government of India plan 70 million children and teens in the program is to involve, depending on the results the pilot. UNICEF called on governmental officials, NGOs and other play a greater play a greater part in this project .
– The Odontoid Curved Drill Guide, a surgical tool on anterior fixing the the dens fractures.